Home / Import refusals / ES9-0007488-3/11/1

FDA Import Refusal ES9-0007488-3/11/1 — Aurobindo Pharma Limited

Aurobindo Pharma Limited — FEI 3007373532

The FDA refused shipment ES9-0007488-3/11/1 from Aurobindo Pharma Limited (India) on November 9, 2022. The refused product falls under Drugs and Biologics — SUMATRIPTAN SUCCINATE (ANTIMIGRAINE AGENT). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
November 9, 2022
Country
India
Product Category
Drugs and Biologics
Product Code
63OCT07 SUMATRIPTAN SUCCINATE (ANTIMIGRAINE AGENT)
Charges
75

Recent inspections

  • 1169446 (VAI Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1105823 (OAI Fri Sep 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1022788 (NAI Sat Jun 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 927596 (NAI Fri Mar 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 787128 (NAI Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 799-7705442-9/12/3 (Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7466939-8/11/1 (Mon Jun 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7444787-8/11/1 (Thu Jun 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7029089-2/11/1 (Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7007876-8/11/1 (Thu Apr 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources